Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced the successful completion of the first procedures using its MWA technology in Vietnam and Argentina. In Vietnam, the first clinical case using the Company's MWA technology was completed at Lac Viet Friendship Hospital on June 18. The procedure was performed by Dr. Dinh Xuan Ha, Dep

Olympus Corporation (Olympus), a global MedTech company committed to advancing endoscopy-enabled care, today announced a reseller agreement with First Nation Group, a premier Service-Disabled Veteran-Owned Small Business (SDVOSB), Veteran-Owned Small Business (VOSB), and Small Business distributor serving federal healthcare customers nationwide.  Under the agreement, First Nation Group will serve as an authorized SDVOSB reseller for Olympus America Inc. (OAI), providing federal

CereVasc, Inc., a clinical-stage medical device company developing novel, minimally invasive treatments for neurological diseases, announced it has completed patient enrollment in its STRIDE pivotal trial evaluating the investigational eShunt System in patients with normal pressure hydrocephalus (NPH). With patient enrollment complete at 32 clinical sites, STRIDE is progressing through remaining treatment and follow-up activities for consented patients, keeping the company on track

Baystate Health, a not-for-profit, integrated health system in western Massachusetts, is expanding its strategic relationship with Oracle Health to create a more connected healthcare experience for patients and clinicians. Through this initiative, Baystate Health plans to accelerate the adoption of Oracle Health technologies across its network, including its health plan, Health New England. This modernization journey will be enabled by AI-powered solutions including Oracle Health EHR, Oracle

Cook Medical’s new SureTome™ SW Sphincterotome with DomeTip® is now available in the United States and Canada. This next-generation sphincterotome enables advanced gastrointestinal endoscopists to easily and reliably access the hepatopancreatobiliary system. SureTome SW is an innovative addition to Cook’s portfolio of Endoscopy devices and continuing pipeline of new products.   The SureTome SW offers key features such as:

Marcus Evans is pleased to announce the return of the Healthcare HR Summit, scheduled for October 19-20, 2026 at the Red Rock Casino Resort and Spa, Las Vegas, Nevada. Now a firmly established fixture in the healthcare HR calendar, the summit convenes the most senior human resources executives from across North America's leading hospital systems and healthcare networks, alongside a carefully selected group of innovative suppliers and solution providers. The Healthcare HR Summit

Flosonics Medical received the Paul and Debra Walker Award, part of the Sepsis Research and Innovation Challenge at the Unite for Sepsis Symposium presented by Sepsis Alliance in Washington, D.C. on June 11, 2026. The recognition comes as FloPatch, the company’s FDA-cleared wearable Doppler ultrasound device, has become a trusted tool for bedside fluid responsiveness assessment across a growing number of U.S. emergency departments and intensive care units. This award recognize

AccurKardia, an innovator in ECG-based diagnostics technology, today announced that its AK-AVS™ aortic valve stenosis (AVS) screening software has been accepted into the U.S. Food and Drug Administration (FDA) Total Product Life Cycle Advisory Program (TAP) pilot. AK-AVS, which received FDA Breakthrough Device Designation in October 2024, is an ECG-based AI algorithm intended to aid in the diagnosis of moderate to severe aortic valve stenosis in adult patients 22 years and older, utiliz

SurGenTec®, a medical device company focused on advancing treatment options for orthopedic and spine surgery, today announced FDA clearance of its ION-L™ Lumbar Facet Fixation System. ION-L™, part of SurGenTec's facet fixation platform, is indicated for the treatment of patients with degenerative disc disease (DDD) from L3 to S1 in skeletally mature patients who have failed conservative care. This clearance is supported by compelling long-term clinical evidence from an Ins

Marcus Evans will host the Healthcare CFO, Financial Strategy & Revenue Cycle Summit at the Red Rock Casino Resort and Spa in Las Vegas, Nevada. This invitation-only, premium Summit brings together senior-level healthcare finance executives and a select group of innovative suppliers and service providers for two days of actionable insight, strategic discussion, and partnership-focused networking. Built around the realities facing today's healthcare finance leaders, the Summi